# Reinnervate

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/reinnervate

- Industry: Biotechnology
- Headquarters: Sedgefield, UK
- Website: www.reinnervate.com
- Total disclosed funding: $7M
- Latest round: Seed (May 28, 2014)
- Investors on record: 2

## About

Reinnervate Ltd. is a UK-based biomedical company that specializes in innovative products and services for stem cell research and drug discovery, enhancing the capabilities of scientific research through advanced 3D cell culture technologies.Founded in 2002 in Sedgefield, UK, Reinnervate Ltd. focuses on the development of biomedical products. In August 2014, the company was acquired by ReproCELL for GBP 2.5 million. The firm has completed a total of 6 deals since its inception.Reinnervate Ltd. offers advanced biomedical products with a strong emphasis on stem cell research and drug discovery. Their flagship product, Alvetex, is a 3D cell culture system that enables the growth of mammalian cells in environments that closely mimic physiological conditions. Alvetex products, such as Alvetex Scaffold and Alvetex Strata, support cell growth and interaction, making them valuable tools for researchers in studying cell behavior. The company serves a wide range of clients, including academic institutions, pharmaceutical companies, and biotechnology firms, distributing its offerings across global markets including the Americas, Europe, and Asia.In the most recent financial year, 2013, Reinnervate Ltd. reported revenue of GBP 191,080.50, alongside an EBITDA loss of GBP 2,491,226.10.Following its acquisition in August 2014, Reinnervate Ltd. plans to leverage the recent funding to enhance product development and expand its market reach. The company aims to launch new innovative products focused on 3D cell culture technologies by 2015, while also targeting growth in emerging markets across Asia and Europe. The funding will be allocated towards research and development as well as marketing efforts to facilitate this expansion.

## Funding rounds

- Seed, May 28, 2014, $0.2M — Northstar Ventures
- Series B, Apr 8, 2011, $4.2M — Northstar Ventures, Parkwalk Advisors
- Series A, Apr 30, 2010, $2.7M — Northstar Ventures

## Investors

- Northstar Ventures (https://capitalatlas.ai/funds/northstar-ventures) — Series A, Series B, Seed
- Parkwalk Advisors (https://capitalatlas.ai/funds/parkwalk-advisors) — Series B